Christopher M. Whelan, MD
Urology
About Christopher M. Whelan, MD
Christopher M. Whelan, MD, is a urological surgeon with Aurora BayCare Urological Surgeons in Green Bay and Manitowoc, Wisconsin.
Dr. Whelan earned his medical degree from Southern Illinois University in Springfield, IL, where he also completed his residency in Urology. Additionally, he pursued a fellowship in Minimally Invasive Urologic Oncology at the City of Hope National Medical Center in Duarte, CA, an NCI-designated Comprehensive Cancer Center known for its advanced robotic surgery and cancer research.
He has performed over 500 robotic surgical procedures for prostate, bladder, and kidney cancers. Dr. Whelan's work has been published in numerous scientific journals, and he has received national awards for his extensive research on prostate and kidney cancer.
Related Medical Services
Locations
Aurora BayCare Medical Center - Aurora BayCare Urological Surgeons
Green Bay
Location Details read_more
BayCare Clinic Lakeside Campus - Aurora BayCare Urological Surgeons
Manitowoc
Location Details read_moreMore from Christopher M. Whelan, MD
Christopher M. Whelan, MD joins Aurora BayCare Urological Surgeons
Read More read_moreCertifications
Board Certified by the American Board of Urology
Education
Southern Illinois University, Springfield, IL
Residency
Southern Illinois University - Urology
Fellowships
City of Hope- Minimally Invasive Urologic Oncology
Professional Associations and Memberships
Whelan C, Schwartz BF: Bilateral guaifenesin ureteral calculi. Urology, 63:1-2, 2004.
Whelan C, McKenna PH Urologic applications of biofeedback therapy. Contemporary
Urology, October 2004.
Whelan C, McKenna PH: Dysfuctional voiding as a co-factor of recurrent UTI.
Contemporary Urology, March 2004.
Whelan C, Stewart J, Schwartz BF: Mechanics of wound healing and importance of
Vacuum Assisted Closure in urology. Journal of Urology, 173(5):1463-70, 2005.
Powell T, Whelan C, Schwartz BF: Laparoscopic renal cryotherapy: Biology,
techniques and outcomes. Minerva Urologica E Nefrologica, 57(2):109-18, 2005.
Whelan C, Sherba L, McKenna PH: Antenatal intervention for bladder neck
obstruction in a twin pregnancy. Dialogues in Pediatric Urology, 27(4):6-7, 2006
Schwartz BF, Rewcastle JC, Powell T, Whelan C, Vestal JC: Renal cryoablation as
primary treatment for localized renal lesions. Urology, 68(Supp 1A):14-18, 2006.
Karnes RJ, Whelan C, Kwon ED: Immunotherapy for prostate cancer. Curr Pharm
Design, 12(7): 807-17, 2006.
Kinsinger C, Tatko C, Whelan C, Wilkinson T: Synthesis of 4-substituted and 1,4-
disubstituted-4-hydroxypyrrolidin-2-ones. Synthetic Comm, 37, 1845-52, 2007.
Kramer BA, Whelan C, Rewcastle JC Vestal JC, Schwartz BF: Increasing the
number of biopsy cores taken before renal cryoablation increases diagnostic yield. J
Endourol, 23: 283-6, 2009.
Kramer BA, Whelan C, Powell T, Schwartz BF: Robotic assisted laparoscopic
sacrocolpopexy as treatment for pelvic organ prolapse. J Endourol, 23: 655-8, 2009.
Lane BR, Whelan CM: The Influence of Surgical Approach to the Renal Mass on
Renal Function. Uro Clinics N America, May 2012.
Lane BR, Whelan CM: Robotic Prostatectomy: Maximizing Cancer Control and
Preservation of Function. SHMG Proceedings, Spring 2012.
Lane BR, Golan S, Eggener S, Tobert C, Whelan C: Differential Use of Parial
Nephrectomy for Intermediate and High Complexity Tumors May Explain Variability in
Reported Utilization Rates. J Urology, Jan 2013
Whelan C, Wilson T, Ruel N, Chan K: Continence Outcomes Following Robotic-
Assisted Cystectomy with Orthotopic Neobladder Diversion. Submitted for publication
Boelkins B, Whelan C, Kahnoski R, Bolthouse J, Lane B: PCA3 Reduces the
Number of Prostate Biopsies in a Community Based Urology Practice. Submitted for
Publication
Whelan C, Crocitto L, Kawachi M, Chan K, Smith D, Wilson T, Smith S: The
influence of PSA yield on the analysis of expressed prostate secretions (EPS) for prostate
cancer diagnosis. Canadian Journal of Urology, Feb 2013.
Whelan C, Kawachi M, Smith D, Linehan J, Babilonia G, Mejia R, Wilson T, Smith
S: EPS Biomarker Improve Stratification of NCCN Active Suveillance Candidates:
Performance of Secretion Capacity and TMPRSS2:ERG Models. Submitted for
Publication